ATE305013T1 - Mittel zur stabilisierung von hämoglobinen - Google Patents

Mittel zur stabilisierung von hämoglobinen

Info

Publication number
ATE305013T1
ATE305013T1 AT00942469T AT00942469T ATE305013T1 AT E305013 T1 ATE305013 T1 AT E305013T1 AT 00942469 T AT00942469 T AT 00942469T AT 00942469 T AT00942469 T AT 00942469T AT E305013 T1 ATE305013 T1 AT E305013T1
Authority
AT
Austria
Prior art keywords
stabilizing
agent
hemoglobin
hemoglobins
stabilizing agent
Prior art date
Application number
AT00942469T
Other languages
English (en)
Inventor
Tsutomu Kakuyama
Original Assignee
Int Reagents Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Int Reagents Corp filed Critical Int Reagents Corp
Application granted granted Critical
Publication of ATE305013T1 publication Critical patent/ATE305013T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00942469T 1999-07-01 2000-07-03 Mittel zur stabilisierung von hämoglobinen ATE305013T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18813299 1999-07-01
PCT/JP2000/004440 WO2001002438A1 (fr) 1999-07-01 2000-07-03 Moyens pour stabiliser les hemoglobines

Publications (1)

Publication Number Publication Date
ATE305013T1 true ATE305013T1 (de) 2005-10-15

Family

ID=16218303

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00942469T ATE305013T1 (de) 1999-07-01 2000-07-03 Mittel zur stabilisierung von hämoglobinen

Country Status (7)

Country Link
EP (1) EP1191037B1 (de)
JP (1) JP5410647B2 (de)
KR (1) KR100674690B1 (de)
AT (1) ATE305013T1 (de)
CA (1) CA2377822A1 (de)
DE (1) DE60022751T2 (de)
WO (1) WO2001002438A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3910156B2 (ja) * 2003-05-28 2007-04-25 アークレイ株式会社 試料の安定化方法
JP5294257B2 (ja) * 2008-11-13 2013-09-18 アルフレッサファーマ株式会社 ヘモグロビンの測定方法および測定用キット
JP5554000B2 (ja) * 2009-02-19 2014-07-23 積水メディカル株式会社 糖化ヘモグロビン測定用試料の測定方法
JPWO2011058958A1 (ja) * 2009-11-10 2013-04-04 富士レビオ株式会社 ヘムタンパク質の安定化用組成物及びそれを用いたヘムタンパク質の安定化方法
JP6467182B2 (ja) * 2014-10-03 2019-02-06 株式会社ビー・エム・エル ヘモグロビンｆの管理試料
CN110441515B (zh) * 2019-07-16 2022-05-27 柏荣诊断产品（上海）有限公司 一种便隐血检测试剂盒
JP7645238B2 (ja) 2020-03-26 2025-03-13 キヤノンメディカルダイアグノスティックス株式会社 ヘモグロビンの影響軽減方法、糖化ヘモグロビンの測定方法、糖化ヘモグロビン測定試薬、及び糖化ヘモグロビン測定キット
CN119912556A (zh) * 2023-10-30 2025-05-02 爱科来株式会社 血红蛋白a2和血红蛋白f的稳定化方法、血红蛋白溶液的制造方法以及血红蛋白溶液

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6137735A (ja) * 1984-07-31 1986-02-22 Terumo Corp ヘモグロビン含有リポソ−ムおよびその製造方法
US5051353A (en) * 1988-08-09 1991-09-24 The United States Of America As Represented By The Secretary Of The Navy Preservation and restoration of hemoglobin in blood substitutes
US5045529A (en) * 1989-03-27 1991-09-03 Bionostics, Inc. Tonometric fluid for blood gas and co-oximetry instruments
ATE136466T1 (de) * 1989-12-29 1996-04-15 Univ Texas Tech Polyhämoglobin durch purinderivate und glutathion stabilisiert
JP3543144B2 (ja) * 1995-03-11 2004-07-14 国際試薬株式会社 臨床検査用製剤
US5929031A (en) * 1995-05-02 1999-07-27 Baxter Biotech Technology Sarl Storage stable hemoglobin solutions
ZA988662B (en) * 1997-10-10 1999-03-31 Baxter Int Storage-stable hemoglobin compositions

Also Published As

Publication number Publication date
EP1191037B1 (de) 2005-09-21
DE60022751T2 (de) 2006-07-13
EP1191037A4 (de) 2003-05-02
WO2001002438A1 (fr) 2001-01-11
CA2377822A1 (en) 2001-01-11
KR100674690B1 (ko) 2007-01-25
EP1191037A1 (de) 2002-03-27
DE60022751D1 (de) 2006-02-02
JP5410647B2 (ja) 2014-02-05
KR20020026463A (ko) 2002-04-10

Similar Documents

Publication Publication Date Title
FI906008A0 (fi) Menetelmä heterosyklisen yhdisteen vesipitoisen seoksen stabiloimiseksi
ATE516304T1 (de) Nrg-2 nukleinsäuren, polypeptide und diagnostische / therapeutische methoden
ATE430759T1 (de) Kationische sterolderivate, ph-sensitive liposomen diese umfassend und verfahren zur wirkstoffbeladung von liposomen
CY1111616T1 (el) Ετεροαρυλ ενωσεις που περιεχουν αζωτο και χρηση αυτων στην αυξηση ενδογενους ερυθροποιητινης
ATE412774T1 (de) Parallele genotypisierung mehrerer patientenproben
DE3889733D1 (de) Vorrichtung zur messung der konzentration und sauerstoffsättigung von hämoglobin.
ATE509120T1 (de) Fusionsproteine zur detektion von analyten
DE60016178D1 (de) Verfahren zur diagnose und zur charakterisierung von schlaganfall
ATE305013T1 (de) Mittel zur stabilisierung von hämoglobinen
ATE451390T1 (de) Polypeptide zur bindung an das b-lymphozyten- stimulatorische protein (blys)
DE69943051D1 (de) Augentropfen enthaltend Ketotifen
ATE195626T1 (de) Taxol enthaltende zusammensetzung zur verwendung in der organkonservierung und als kardioplegisches mittel
EP1269917A4 (de) Gerät und verfahren zur messung von biologischen informationen
DE60211651D1 (de) Proteom-analyseverfahren
ATE72052T1 (de) Bestimmung von glycohaemoglobin (glycosyliertem haemoglobin) in blut.
DE60012820D1 (de) Zusammensetzungen zur Stabilisierung von sauerstoffempfindlichen Verbindungen
Altland et al. Isoelectric focusing of basic proteins: the problem of oxidation of cysteines
EP1428537A4 (de) Antikörper enthaltende stabilisierte zubereitungen
DE59914955D1 (de) Multiküvettenrotor
SE9604378D0 (sv) Methods and reagents for determining protein S
ATE325336T1 (de) Sensormembran zur bestimmung von sauerstoffkonzentrationen
DE60126864D1 (de) Verfahren zur Herstellung von (E,Z) 3-(2-aminoethoxyimino)-androstane-6,17-dione und Analoge
PL326266A1 (en) Cyanide containing haemoglobin determination reagent composition and method of ensuring required precision, accuracy and non-interference by leucoytes of haemoglobin determination processes in autoamtic hamatological analysers
EP1120648A4 (de) Verfahren zur feststellung von einer thiol enthaltenden zusammensetzung
ATE267018T1 (de) Verwendung von peptidverbindungen zur behandlung von sle

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties